Prevalence, Clinical Correlates, Cognitive Trajectories, and Dementia Risk Associated With Mild Behavioral Impairment

Cheuk Ni Kan1, Jemellee Cano2, Xuhao Zhao3

  • 1Memory Aging & Cognition Centre, Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Insights

Mild behavioral impairment (MBI) in older adults is linked to faster cognitive decline and a significantly higher risk of developing dementia. Early identification of MBI is crucial for dementia prevention strategies.

Area of Science:

  • Neuroscience
  • Gerontology
  • Psychiatry

Background:

  • Mild behavioral impairment (MBI) involves persistent neuropsychiatric symptoms in later life.
  • The prognostic impact of MBI, particularly in Asian populations, requires further investigation.
  • This study examines MBI's epidemiology in a Singaporean elderly cohort.

Purpose of the Study:

  • To investigate the epidemiologic characteristics of MBI in a prospective Singaporean elderly cohort.
  • To evaluate the long-term cognitive and prognostic impact of MBI.
  • To assess MBI as a potential risk factor for dementia.

Main Methods:

  • Recruited 304 dementia-free elderly individuals (mean age 72.2 years).
  • Conducted annual neuropsychological, neuropsychiatric, and clinical assessments for 4 years.
  • Assessed MBI using baseline and year-1 Neuropsychiatric Inventory, and diagnosed cognitive status (NCI, CIND).

Main Results:

  • MBI prevalence was 14.5%, higher in those with cognitive impairment.
  • MBI patients exhibited poorer baseline cognitive function, primarily in memory and executive domains.
  • MBI was associated with accelerated global cognitive decline and faster increases in Clinical Dementia Rating Sum-of-Boxes scores.
  • 38.6% of MBI patients developed dementia versus 12.3% of non-MBI individuals, a 2.56-fold increased risk.

Conclusions:

  • MBI is a significant neurobehavioral risk factor for dementia.
  • MBI serves as a potential target for dementia risk modeling and preventive interventions.
  • Findings highlight the importance of addressing MBI in dementia risk assessment and management.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
650
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
159
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
250
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
194
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
171
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
225